NGM BIOPHARMACEUTICALS INC — Form D/A

NGM BIOPHARMACEUTICALS INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2011-11-07. The offering totals $55.7M, of which $55.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Marc V LeschlyDirectorPalo Alto, CA
Arthur D LevinsonDirectorSouth San Francisco, CA
William V RieflinDirectorSouth San Francisco, CA
David D SchnellDirectorPalo Alto, CA
Peter D SvennilsonDirectorGulf Stream, FL
Helen KimExecutive OfficerSan Diego, CA
William V RieflinExecutive OfficerSouth San Francisco, CA
William J RieflinDirectorSouth San Francisco, CA
William J RieflinExecutive OfficerSouth San Francisco, CA
David GoeddelDirectorAgoura Hills, CA
David GoeddelExecutive OfficerAgoura Hills, CA
David V GoeddelDirectorSouth San Francisco, CA
David V GoeddelExecutive OfficerSouth San Francisco, CA
PETER V SVENNILSONDirectorSAN FRANCISCO, CA
Mark V LeschlyDirectorPalo Alto, CA
David V SchnellDirectorPalo Alto, CA
Jin-Long ChenDirectorSouth San Francisco, CA
Jin-Long ChenExecutive OfficerSouth San Francisco, CA
McHenry T Tichenor, Jr.DirectorDallas, TX
Arthur V LevinsonDirectorSouth San Francisco, CA
Helen V KimExecutive OfficerSouth San Francisco, CA
Luis BayolExecutive OfficerSouth San Francisco, CA
Marc LeschlyDirectorPalo Alto, CA

Other filings by this issuer (9)

FiledFormOfferingSold
2015-03-25D$106.0M$106.0M
2015-02-24D$60.0M$20.7M
2013-05-03D$50.0M$13.5M
2011-11-03D/A$55.7M$38.5M
2010-05-03D/A$55.7M$21.5M
2010-04-05D$51.1M$17.0M
2009-12-22D/A$26.6M$26.6M
2009-12-10D/A$26.6M$24.5M
2009-11-13D/A$26.6M$17.6M

More